Between 30 and 40 % of patients suffering from major depressive disorder will develop treatment-resistant depression (TRD), classically described as a lack of satisfactory response to two or more adequate antidepressant trials . For these patients, a well-established approach is transcranial magnetic stimulation (TMS).